US Pharma MarketingThe post Summit debuts longer-term ivonescimab data as it awaits FDA NSCLC decision appeared first on Clinical Trials Arena.
Summit debuts longer-term ivonescimab data as it awaits FDA NSCLC decision
Summit has already filed for ivonescimab’s approval in NSCLC to the FDA. The post Summit debuts longer-term ivonescimab data as it awaits FDA NSCLC decision appeared first on Clinical Trials Arena .
Summit has already filed for ivonescimab’s approval in NSCLC to the FDA.
Source: Clinical Trials Arena